tiprankstipranks
Trending News
More News >
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
US Market

PharmaCyte Biotech (PMCB) Financial Statements

Compare
261 Followers

PharmaCyte Biotech Financial Overview

PharmaCyte Biotech's market cap is currently $9.33M. The company's EPS TTM is $0.76; its P/E ratio is -0.70; PharmaCyte Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -4.38M$ -6.52M$ -6.46M$ -4.39M$ -3.62M
EBITDA$ 30.66M$ 6.85M$ -4.32M$ -4.24M$ -3.55M
Net Income$ 30.66M$ 333.76K$ -4.32M$ -4.24M$ -3.55M
Balance Sheet
Cash & Short-Term Investments$ 15.54M$ 50.18M$ 68.04M$ 85.40M$ 2.20M
Total Assets$ 55.17M$ 59.90M$ 73.28M$ 90.62M$ 7.40M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 50.80K
Net Debt$ -15.17M$ -50.18M$ -68.04M$ -85.40M$ -2.15M
Total Liabilities$ 3.28M$ 20.39M$ 586.58K$ 704.37K$ 724.78K
Stockholders' Equity$ 51.89M$ 39.51M$ 72.69M$ 89.92M$ 6.68M
Cash Flow
Free Cash Flow$ -2.98M$ -2.15M$ -3.79M$ -4.12M$ -3.33M
Operating Cash Flow$ -2.98M$ -2.15M$ -3.79M$ -4.12M$ -3.33M
Investing Cash Flow$ -7.00M$ -5.00M$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ -25.03M$ -10.71M$ -13.56M$ 87.31M$ 4.64M
Currency in USD

PharmaCyte Biotech Earnings and Revenue History

PharmaCyte Biotech Debt to Assets

PharmaCyte Biotech Cash Flow

PharmaCyte Biotech Forecast EPS vs Actual EPS